ArticleComputers in biology and medicine2025
Establishment of a machine learning-based prediction framework to assess trade-offs in decisions that affect post-HCT outcomes.
Article in Computers in biology and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In this study, we propose a conceptual framework of decision support tools, built upon machine learning and multi-objective optimization, aimed at offering a deeper understanding of the complex trade-offs involved in hematopoietic stem cell transplantation (HCT) across various blood diseases. Our main contribution is in proposing a means to assess benefits and risks across choices that affect multiple outcomes post-HCT, such as overall survival, event-free survival, rejection, relapse, and graft-versus-host disease. We elaborate on the development of machine learning models for predicting HCT outcomes, discuss the potential insights these models might offer, and propose how decision support tools could be informed by these insights. Our framework is demonstrated using an extensive Center for International Blood and Marrow Transplant Research (CIBMTR) HCT dataset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.